CONCLUSIONS
PVP‐I
PLAQUE
CHX and PVP‐I efficacy lasted for 3 days, and PVP‐I did not demonstrate superior plaque control to CHX in toddlers. Chemical plaque control agents should be considered an adjunct to mechanical methods, not an alternative. Further studies are needed to confirm these findings and to determine the long‐term efficacy and safety of these antiplaque agents in toddlers.